|

FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin) Clinical Trials

4 actively recruiting trials across 1 location

No change since July 2026

Pipeline

Phase 2: 2Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Maimónides Biomedical Research Institute of Córdoba1
  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences1
  • Fudan University1
  • Crossignal Therapeutics, Inc.1

Indications

  • Cancer4
  • Colorectal Cancer2
  • Gastric Cancer (Diagnosis)1
  • Locally Advanced Colorectal Cancer1
  • Gastroesophageal Junction Adenocarcinoma1

Other3 trials

Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Colon Cancer
Phase 3
Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer
Phase 2
TAIC FOLFOX for Locally Advanced G/GEJA
Phase 2

Houston, Texas1 trial

A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

MD Anderson Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.